The circulating levels of complement-Clq/TNF-related protein 13 (CTRP13) in patients with type 2 diabetes and its association with insulin resistance

Clinical Laboratory

Volumn 63, Issue 2, 2017, Pages 327-333

  Afrookhteh, Abolfazl ^a   Emamgholipour, Solaleh ^b   Alipoor, Behnam ^c   Moradi, Nariman ^b   Meshkani, Reza ^b   Nasli Esfahani, Ensieh ^d   Rahimipour, Ali ^b   Shanaki, Mehrnoosh ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; CTRP13; Insulin resistance; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; COMPLEMENT C1Q TUMOR NECROSIS FACTOR RELATED PROTEIN 13; COMPLEMENT COMPONENT C1Q; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; CTRP13 PROTEIN, HUMAN; INSULIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD BIOCHEMISTRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; YOUDEN INDEX; ANALYSIS; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC;

ADIPOKINES; ADIPONECTIN; AREA UNDER CURVE; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COMPLEMENT C1Q; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 85016334688     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2016.160609     Document Type: Article

References (29)

1. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002;156:714-9 (PMID: 12370159).
2. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-46 (PMID: 15823385).
3. Morgan CL, Currie CJ, Peters JR. Relationship between diabetes and mortality: A population study using record linkage. Diabetes Care 2000;23:1103-7 (PMID: 10937505).
4. Muoio DM, Newgard CB. Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:193-205 (PMID: 18200017).
5. Al-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: The missing link between endocrine metabolic disorders and immunity. Eur J Med Res 2013;18:1-13 (PMID: 23634778).
6. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: The missing link between insulin resistance and obesity. Diabetes Metab 2008;34:2-11 (PMID: 18093861).
7. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23:963-74 (PMID: 15380884).
8. Hatzis G, Deftereos S, Tousoulis D, et al. Adiponectin: merely a bystander or the missing link to cardiovascular disease? Curr Top Med Chem 2013;13:139-63 (PMID: 23470075).
9. Choi KM, Hwang SY, Hong HC, et al. Clq/TNF-related protein- 3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes 2012;61:2932-6 (PMID: 22837306).
10. Tang JN, Shen DL, Liu CL, et al. Plasma levels of Clq/TNF-re- lated protein 1 and interleukin 6 in patients w ith acute coronary syndrome or stable angina pectoris. Am J Med Sci 2015;349:130-6 (PMID: 25635749).
11. Qu H, Deng M, Wang H, et al. Plasma CTRP-3 concentrations in Chinese patients with obesity and type II diabetes negatively correlate with insulin resistance. J Clin Lipidol 2015;9:289-94 (PMID: 26073386).
12. Schaffler A, Buechler C. CTRP family: linking immunity to me- tabolism. Trends Endocrinol Metab 2012;23:194-204 (PMID: 222 61190).
13. Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord 2014;15: 111-23. (PMID: 23963681).
14. Peterson JM, Wei Z, Seldin MM, et al. CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol 2013;305: R522-R33 (PMID: 23842676).
15. Park SY, Choi JH, Ryu HS, et al. Clq tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA- depleted myocytes and activates AMP-activated protein kinase. J Biol Chem 2009;284:27780-9 (PMID: 19651784).
16. Wei Z, Peterson JM, Lei X, et al. Clq/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem 2012;287:10301-15 (PMID: 22275362).
17. Chalupova L, Zakovska A, Adamcova K. Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1: A pilot study: measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome. Clin Biochem 2013;46:73-8 (PMID: 23000311).
18. Lu L, Zhang RY, Wang XQ, et al. Clq/TNF-related protein-1: An adipokine marking and promoting atherosclerosis. Eur Heart J. 2016 Jun 7;37(22): 1762-71 PMID: 26705391).
19. Shabani P, Naeimi Khaledi H, Beigy M, et al. Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD) is it through insulin resistance? PLoS One 2015;10:e0118650 (PMID: 25767880).
20. Xin Y, Lyu X, Wang C, et al. Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocr J 2014; 61:841-7 (PMID: 24965225).
21. Emamgholipour S, Moradi N, Beigy M, et al. The association of circulating levels of complement-Clq TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: A case-control study. Diabetol Metab Syndr 2015;7:108 (PMID: 26613006).
22. Byerly MS, Swanson R, Wei Z, et al. A central role for Clq/TNF-related protein 13 (CTRP13) in modulating food intake and body weight. PLoS One 2013;8:e62862 (PMID: 23638159).
23. Wei Z, Peterson JM, Wong GW. Metabolic Regulation by Clq/TNF-related Protein-13 (CTRP13) Activation of Amp-Activated Protein Kinase And Suppression of Fatty Acid-Induced JNK Signaling. Journal of Biological Chemistry 2011;286:15652-65 (PMID: 21378161).
24. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79 (PMID: 22517736).
25. Choi KM, Hwang SY, Hong HC, et al. Clq/TNF-related protein- 3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes 2012;61:2932-6 (PMID: 22837306).
26. Choi HY, Park JW, Lee N, et al. Effects of a combined aerobic and resistance exercise program on Clq/TNF-related protein-3 (CTRP-3) and CTRP-5 levels. Diabetes Care 2013;36:3321-7 (PMID: 23780948).
27. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86: 1930-5 (PMID: 11344187).
28. Yatagai T, Nagasaka S, Taniguchi A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52:1274-8 (PMID: 14564678).
29. Choi KM, Hwang SY, Hong HC, et al. Implications of Clq/TNF- related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc Diabe-tol 2014; 13:14 (PMID: 24417980).